Aliases & Classifications for Suppression Amblyopia

MalaCards integrated aliases for Suppression Amblyopia:

Name: Suppression Amblyopia 12 15
Amblyopia 43 71
Amblyopia, Suppression 71
Strabismic Amblyopia 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10375
ICD9CM 34 368.01
MeSH 43 D000550
SNOMED-CT 67 35600002
ICD10 32 H53.03
UMLS 71 C0002418 C0750903

Summaries for Suppression Amblyopia

MalaCards based summary : Suppression Amblyopia, also known as amblyopia, is related to paralytic squint and astigmatism, and has symptoms including photophobia, other specified visual disturbances and visual disturbance. An important gene associated with Suppression Amblyopia is PLAAT3 (Phospholipase A And Acyltransferase 3). The drugs Tropicamide and Atropine have been mentioned in the context of this disorder. Affiliated tissues include eye, testes and cortex.

Related Diseases for Suppression Amblyopia

Diseases related to Suppression Amblyopia via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 267, show less)
# Related Disease Score Top Affiliating Genes
1 paralytic squint 31.9 PLAAT3 PHOX2A MTRNR2L5
2 astigmatism 31.5 DSE DPT
3 accommodative esotropia 30.6 PLAAT3 PHOX2A
4 hypotropia 30.4 PLAAT3 PHOX2A
5 monofixation syndrome 30.3 TNFRSF10C PLAAT3
6 congenital ptosis 30.2 PHOX2A DPT
7 ocular motility disease 30.2 PLAAT3 PHOX2A
8 esotropia 30.0 PLAAT3 PHOX2A DSE DPT
9 anisometropia 30.0 TNFRSF10C PLAAT3 DSE DPT
10 exotropia 29.9 PLAAT3 PHOX2A DPT
11 cycloplegia 29.8 DSE DPT
12 aniseikonia 29.6 PLAAT3 DSE DPT
13 facial paralysis 29.5 MTRNR2L5 MTRNR2L4
14 hypertropia 29.5 PLAAT3 PHOX2A DPT
15 strabismus 28.5 TNFRSF10C PLAAT3 PHOX2A DSE DPT
16 amblyopia 28.5 TNFRSF10C SIRPA PLAAT3 PHOX2A HNMT DSE
17 ametropic amblyopia 28.4 PHOX2A MTRNR2L5 MTRNR2L4 DSE DPT
18 disuse amblyopia 12.5
19 mental and growth retardation with amblyopia 12.2
20 microphthalmia, isolated 6 11.6
21 farsightedness 11.6
22 duane retraction syndrome 1 11.5
23 peters-plus syndrome 11.4
24 hemifacial hyperplasia with strabismus 11.4
25 isolated ectopia lentis 11.4
26 microphthalmia 11.4
27 blepharophimosis, ptosis, and epicanthus inversus 11.2
28 duane retraction syndrome 2 11.2
29 corneal dystrophy, congenital stromal 11.2
30 bestrophinopathy, autosomal recessive 11.2
31 cerulean cataract 11.2
32 aniridia 1 11.1
33 aniridia and absent patella 11.1
34 cataract 41 11.1
35 fibrosis of extraocular muscles, congenital, 1 11.1
36 bornholm eye disease 11.1
37 fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement 11.1
38 mental retardation, anterior maxillary protrusion, and strabismus 11.1
39 cognitive impairment with or without cerebellar ataxia 11.1
40 duane retraction syndrome 3 with or without deafness 11.1
41 aniridia 2 11.1
42 cataract microcornea syndrome 11.1
43 hivep2-related intellectual disability 11.1
44 isolated duane retraction syndrome 11.1
45 monocular esotropia 10.8
46 ptosis 10.6
47 refractive error 10.6
48 eye disease 10.6
49 pathologic nystagmus 10.6
50 ocular dominance 10.5
51 hemangioma 10.4
52 microvascular complications of diabetes 5 10.4
53 alternating exotropia 10.4
54 scotoma 10.4
55 47,xyy 10.4
56 lacrimal duct defect 10.3
57 optic nerve disease 10.3
58 prosopagnosia 10.2 TNFRSF10C HNMT
59 intraocular pressure quantitative trait locus 10.2
60 achromatopsia 10.2
61 3-methylglutaconic aciduria, type iii 10.2
62 macular degeneration, age-related, 1 10.2
63 familial cold autoinflammatory syndrome 3 10.2
64 myopia 10.2
65 acute retrobulbar neuritis 10.2
66 neuritis 10.2
67 retinal vascular disease 10.2
68 conjunctivitis 10.2
69 cataract 10.2
70 cyclotropia 10.2
71 posttransplant acute limbic encephalitis 10.2
72 autotopagnosia 10.2 TNFRSF10C HNMT
73 ocular motor apraxia 10.2
74 neuropathy 10.2
75 retinal detachment 10.1
76 optic neuritis 10.1
77 uveitis 10.1
78 dyslexia 10.1
79 epithelial-stromal tgfbi dystrophy 10.1 TNFRSF10C HNMT
80 alcohol dependence 10.1
81 keratoconus 10.1
82 brown's tendon sheath syndrome 10.1
83 blepharophimosis 10.1
84 capillary hemangioma 10.1
85 exudative vitreoretinopathy 1 10.0
86 keratitis, hereditary 10.0
87 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
88 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.0
89 vitamin b12 deficiency 10.0
90 nutritional optic neuropathy 10.0
91 abnormal retinal correspondence 10.0
92 alcohol use disorder 10.0
93 keratopathy 10.0
94 crohn's disease 10.0
95 albinism 10.0
96 48,xyyy 10.0
97 color vision deficiency 10.0
98 cerebral visual impairment 10.0
99 hereditary optic neuropathy 10.0
100 mechanical strabismus 10.0
101 lattice corneal dystrophy 10.0 TNFRSF10C HNMT
102 cleft palate, isolated 9.9
103 corneal dystrophy, posterior polymorphous, 1 9.9
104 neurofibromatosis, type iv, of riccardi 9.9
105 optic nerve hypoplasia, bilateral 9.9
106 polykaryocytosis inducer 9.9
107 retinoblastoma 9.9
108 torticollis 9.9
109 charge syndrome 9.9
110 leber optic atrophy 9.9
111 kearns-sayre syndrome 9.9
112 brown syndrome 9.9
113 hydrops, lactic acidosis, and sideroblastic anemia 9.9
114 ocular albinism 9.9
115 persistent hyperplastic primary vitreous 9.9
116 autosomal dominant non-syndromic intellectual disability 1 9.9
117 sleeping sickness 9.9
118 trypanosomiasis 9.9
119 synostosis 9.9
120 color blindness 9.9
121 cerebral palsy 9.9
122 craniosynostosis 9.9
123 corneal dystrophy 9.9
124 astrocytoma 9.9
125 macular retinal edema 9.9
126 familial retinoblastoma 9.9
127 peripheral nervous system disease 9.9
128 juvenile pilocytic astrocytoma 9.9
129 chickenpox 9.9
130 keratoconjunctivitis 9.9
131 neurofibroma 9.9
132 syndromic craniosynostosis 9.9
133 pik3ca-related overgrowth syndrome 9.9
134 yemenite deaf-blind hypopigmentation syndrome 9.9
135 facial nerve disease 9.9 MTRNR2L5 MTRNR2L4
136 abducens palsy 9.8
137 adie pupil 9.8
138 alzheimer disease 9.8
139 anisocoria 9.8
140 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.8
141 catatrichy 9.8
142 coloboma of macula 9.8
143 deafness, unilateral 9.8
144 epicanthus 9.8
145 epidermoid cysts 9.8
146 hand skill, relative 9.8
147 attention deficit-hyperactivity disorder 9.8
148 lipomatosis, multiple 9.8
149 moebius syndrome 9.8
150 pernicious anemia 9.8
151 prader-willi syndrome 9.8
152 sturge-weber syndrome 9.8
153 chromosome 2q35 duplication syndrome 9.8
154 telecanthus 9.8
155 vitiligo-associated multiple autoimmune disease susceptibility 6 9.8
156 williams-beuren syndrome 9.8
157 autism 9.8
158 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.8
159 corneal dystrophy, band-shaped 9.8
160 myasthenia gravis 9.8
161 retinitis pigmentosa 9.8
162 retinoschisis of fovea 9.8
163 coats disease 9.8
164 retinoschisis 1, x-linked, juvenile 9.8
165 ataxia and polyneuropathy, adult-onset 9.8
166 stroke, ischemic 9.8
167 branchiootic syndrome 1 9.8
168 aceruloplasminemia 9.8
169 pars planitis 9.8
170 meningioma, radiation-induced 9.8
171 vitiligo-associated multiple autoimmune disease susceptibility 1 9.8
172 body mass index quantitative trait locus 1 9.8
173 meningioma, familial 9.8
174 myopia 6 9.8
175 myopia 9 9.8
176 human immunodeficiency virus type 1 9.8
177 leptin deficiency or dysfunction 9.8
178 carbonic anhydrase va deficiency, hyperammonemia due to 9.8
179 deficiency anemia 9.8
180 foodborne botulism 9.8
181 posterior polar cataract 9.8
182 brachydactyly 9.8
183 fetal alcohol spectrum disorder 9.8
184 metabolic acidosis 9.8
185 proximal symphalangism 9.8
186 autism spectrum disorder 9.8
187 aphasia 9.8
188 sclerocornea 9.8
189 cornea plana 9.8
190 anterior segment dysgenesis 9.8
191 fibrous dysplasia 9.8
192 neuroretinitis 9.8
193 pleomorphic lipoma 9.8
194 juvenile glaucoma 9.8
195 meningocele 9.8
196 amnestic disorder 9.8
197 hemiplegia 9.8
198 corneal edema 9.8
199 chlamydia 9.8
200 keratomalacia 9.8
201 pituitary apoplexy 9.8
202 arteriovenous malformation 9.8
203 lens subluxation 9.8
204 spinal meningioma 9.8
205 accommodative spasm 9.8
206 presbyopia 9.8
207 goiter 9.8
208 punctate epithelial keratoconjunctivitis 9.8
209 dysentery 9.8
210 entropion 9.8
211 locked-in syndrome 9.8
212 intermediate uveitis 9.8
213 quadriplegia 9.8
214 lagophthalmos 9.8
215 shipyard eye 9.8
216 alexia 9.8
217 irregular astigmatism 9.8
218 lacrimal duct obstruction 9.8
219 methylmalonic acidemia 9.8
220 leber congenital amaurosis 9.8
221 cholera 9.8
222 conversion disorder 9.8
223 pulmonary tuberculosis 9.8
224 cellulitis 9.8
225 retinitis 9.8
226 articulation disorder 9.8
227 juvenile xanthogranuloma 9.8
228 hypotrichosis 9.8
229 secretory meningioma 9.8
230 lymphoplasmacyte-rich meningioma 9.8
231 endophthalmitis 9.8
232 somatoform disorder 9.8
233 movement disease 9.8
234 cavernous hemangioma 9.8
235 neurotic disorder 9.8
236 plexiform neurofibroma 9.8
237 retinal disease 9.8
238 cerebrovascular disease 9.8
239 placenta disease 9.8
240 corneal ulcer 9.8
241 night blindness 9.8
242 herpes simplex 9.8
243 learning disability 9.8
244 waardenburg's syndrome 9.8
245 exophthalmos 9.8
246 iridocyclitis 9.8
247 congenital nystagmus 9.8
248 meibomian cyst 9.8
249 adamtsl4-related eye disorders 9.8
250 isolated methylmalonic acidemia 9.8
251 encephalocele 9.8
252 neonatal stroke 9.8
253 vernal keratoconjunctivitis 9.8
254 weber syndrome 9.8
255 woolly hair syndrome 9.8
256 depression 9.8
257 dysphagia 9.8
258 headache 9.8
259 traumatic brain injury 9.8
260 basal encephalocele 9.8
261 spasmus nutans 9.8
262 cyanide poisoning 9.8
263 juvenile myasthenia gravis 9.8
264 extensive peripapillary myelinated nerve fibers 9.8
265 digitalis poisoning 9.8
266 cranial nerve disease 9.8 PLAAT3 PHOX2A
267 eye accommodation disease 9.5 TNFRSF10C DSE DPT

Graphical network of the top 20 diseases related to Suppression Amblyopia:



Diseases related to Suppression Amblyopia

Symptoms & Phenotypes for Suppression Amblyopia

UMLS symptoms related to Suppression Amblyopia:


photophobia, other specified visual disturbances, visual disturbance

Drugs & Therapeutics for Suppression Amblyopia

Drugs for Suppression Amblyopia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 107, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tropicamide Approved, Investigational Phase 4 1508-75-4 5593
2
Atropine Approved, Vet_approved Phase 4 51-55-8, 5908-99-6 174174
3
Donepezil Approved Phase 4 120014-06-4 3152
4
Brinzolamide Approved Phase 4 138890-62-7 68844
5
Ketorolac Approved Phase 4 66635-83-4, 74103-06-3 3826
6
Nepafenac Approved, Investigational Phase 4 78281-72-8 151075
7
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
8
Polyestradiol phosphate Approved Phase 4 28014-46-2
9
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
10
Cefpirome Approved Phase 4 84957-29-9 5479539
11
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
12
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
13
Sotalol Approved Phase 4 3930-20-9, 959-24-0 5253
14 Mydriatics Phase 4
15 Respiratory System Agents Phase 4
16 Adjuvants, Anesthesia Phase 4
17 Bronchodilator Agents Phase 4
18 Cholinergic Antagonists Phase 4
19 Muscarinic Antagonists Phase 4
20 Parasympatholytics Phase 4
21 Anti-Asthmatic Agents Phase 4
22 Nootropic Agents Phase 4
23 Cholinesterase Inhibitors Phase 4
24 Ophthalmic Solutions Phase 4
25 Anti-Inflammatory Agents Phase 4
26 Carbonic Anhydrase Inhibitors Phase 4
27 Analgesics, Non-Narcotic Phase 4
28 Anti-Inflammatory Agents, Non-Steroidal Phase 4
29 Analgesics Phase 4
30 Cyclooxygenase Inhibitors Phase 4
31 Antirheumatic Agents Phase 4
32 Ketorolac Tromethamine Phase 4
33 Anti-Infective Agents Phase 4
34 Contraceptive Agents Phase 4
35 Antibiotics, Antitubercular Phase 4
36 Contraceptives, Oral, Combined Phase 4
37 Cephalosporins Phase 4
38 Norgestimate, ethinyl estradiol drug combination Phase 4
39 Estradiol 17 beta-cypionate Phase 4
40 Contraceptives, Oral Phase 4
41 Anti-Bacterial Agents Phase 4
42 Topoisomerase Inhibitors Phase 4
43 Estradiol 3-benzoate Phase 4
44 Autonomic Agents Phase 4
45 Sympatholytics Phase 4
46 Sodium Channel Blockers Phase 4
47 Diuretics, Potassium Sparing Phase 4
48
Carbidopa Approved Phase 3 28860-95-9 34359
49
Levodopa Approved Phase 3 59-92-7 6047
50
Ibuprofen Approved Phase 2, Phase 3 15687-27-1 3672
51
Guaifenesin Approved, Investigational, Vet_approved Phase 2, Phase 3 93-14-1 3516
52
Acetaminophen Approved Phase 2, Phase 3 103-90-2 1983
53
Aspirin Approved, Vet_approved Phase 2, Phase 3 50-78-2 2244
54
Acetazolamide Approved, Vet_approved Phase 2, Phase 3 59-66-5 1986
55
Codeine Approved, Illicit Phase 2, Phase 3 76-57-3 5284371
56
Naproxen Approved, Vet_approved Phase 2, Phase 3 22204-53-1 1302 156391
57 Aromatic Amino Acid Decarboxylase Inhibitors Phase 3
58 Antiparkinson Agents Phase 3
59 Central Nervous System Depressants Phase 2, Phase 3
60 Fibrinolytic Agents Phase 2, Phase 3
61 Platelet Aggregation Inhibitors Phase 2, Phase 3
62 Natriuretic Agents Phase 2, Phase 3
63 Anticonvulsants Phase 2, Phase 3
64 Narcotics Phase 2, Phase 3
65 Antipyretics Phase 2, Phase 3
66 Chlorpheniramine, phenylpropanolamine drug combination Phase 2, Phase 3
67 Analgesics, Opioid Phase 2, Phase 3
68 Antitussive Agents Phase 2, Phase 3
69 diuretics Phase 2, Phase 3
70
Folic acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
71 Trace Elements Phase 2
72 Vitamins Phase 2
73 Vitamin B Complex Phase 2
74 Micronutrients Phase 2
75 Vitamin B9 Phase 2
76 Nutrients Phase 2
77 Folate Phase 2
78 Omega 3 Fatty Acid Phase 1, Phase 2
79
Maleic acid Experimental, Investigational Phase 1 110-17-8, 110-16-7 444972
80
Calcium carbonate Approved, Investigational 471-34-1
81 Tomato Approved
82
Dexamethasone acetate Approved, Investigational, Vet_approved 1177-87-3
83
Dexamethasone Approved, Investigational, Vet_approved 50-02-2 5743
84
Propranolol Approved, Investigational 525-66-6 4946
85
Dopamine Approved 51-61-6, 62-31-7 681
86
Cocaine Approved, Illicit 50-36-2 5760 446220
87
Acetylcholine Approved, Investigational 51-84-3 187
88
Methamphetamine Approved, Illicit 537-46-2 10836
89 Curare
90 Protective Agents
91 Antioxidants
92 HIV Protease Inhibitors
93
protease inhibitors
94 Antiemetics
95 Gastrointestinal Agents
96 glucocorticoids
97 Antineoplastic Agents, Hormonal
98 BB 1101
99 Hormone Antagonists
100 Hormones
101 Dopamine Agents
102 Anesthetics
103 Cholinergic Agents
104 Acetylcholine Release Inhibitors
105 Botulinum Toxins
106 Sympathomimetics
107 Dopamine Uptake Inhibitors

Interventional clinical trials:

(showing 154, show less)
# Name Status NCT ID Phase Drugs
1 Pilot Study of Prevention Myopia in Children With Low Concentration of Atropine Unknown status NCT00541177 Phase 4 atropine;tropicamide
2 The Effect of Donepezil on Perceptual Learning in Adult Amblyopia Completed NCT03109314 Phase 4 Donepezil
3 A Randomized Trial Comparing Daily Atropine Versus Weekend Atropine Completed NCT00094614 Phase 4 Atropine
4 Mini-flared Kelman Tip and Reverse Tip With Torsional Phaco: Prospective Randomized Comparative Study Completed NCT02089698 Phase 4
5 Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome Completed NCT01312402 Phase 4 topical brinzolamide 1% in 5mL ophthalmic medication;Placebo in 5 mL dispenser
6 Comparison of Ketorolac Tromethamine 0.4% and Nepafenac 0.1% for the Prevention of Cystoid Macular Edema After Phacoemulsification: Prospective Randomized Double-masked Study Completed NCT02084576 Phase 4 Nepafenac;Ketorolac
7 Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration Completed NCT00280514 Phase 4 cefpirome and moxifloxacin administration
8 A Pilot and Feasibility Study to Determine if a Common Atrial Fibrillation Risk Locus Modulates Differential Response to Antiarrhythmic Drugs Recruiting NCT02347111 Phase 4 Flecainide;Sotalol
9 Topical Timolol for the Treatment of Benign Vascular Periocular Lesions Withdrawn NCT01250457 Phase 4 topical Timolol
10 Clinical Evaluation of the Use of Sealed Capsule Irrigation With Sodium Chloride During Pediatric Cataract Surgery and IOL Implantation Withdrawn NCT00366613 Phase 4
11 Vision In Preschoolers Study (VIP Study) Unknown status NCT00038753 Phase 3
12 Anisometropia Amblyopia Improved by Perceptual Learning and Patching Completed NCT00498641 Phase 3
13 A Randomized Trial of Levodopa as Treatment for Residual Amblyopia (ATS 17) Completed NCT01190813 Phase 3 Levodopa/Carbidopa;Placebo
14 A Randomized Trial Comparing Part-time Versus Minimal-time Patching for Moderate Amblyopia Completed NCT00094679 Phase 3
15 Increasing Patching for Amblyopia in Children 3 to < 8 Years Old Completed NCT00945100 Phase 3
16 A Randomized Trial Comparing Near Versus Distance Activities While Patching for Amblyopia in Children 3 to <7 Years Old Completed NCT00315198 Phase 3
17 A Randomized Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye As Prescribed Treatments for Amblyopia in Children 3 to <7 Years Old Completed NCT00315302 Phase 3 Atropine
18 A Randomized Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia Completed NCT00094744 Phase 3
19 Electronic Recording of Compliance With Occlusion Therapy for Amblyopia: 1 Effects of Patient Education on Compliance 2 Predictors for Non-Compliance Completed NCT00131729 Phase 3
20 Amblyopia Treatment Study: Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia Completed NCT00000170 Phase 3 Atropine
21 Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old Completed NCT00944710 Phase 3 Atropine;Atropine
22 An Evaluation of Treatment of Amblyopia in 7 To <18 Year Olds Completed NCT00094692 Phase 3 atropine
23 Amblyopia Treatment Study Completed NCT00001864 Phase 3 Atropine
24 A Randomized Trial of Full-time Bangerter Filters Versus Part-time Daily Patching for the Treatment of Moderate Amblyopia in Children Completed NCT00525174 Phase 3
25 A Randomized Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children 3 to <7 Years Old Completed NCT00091923 Phase 3
26 A Randomized Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds Completed NCT00315328 Phase 3 Atropine
27 Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity Completed NCT01203436 Phase 2, Phase 3
28 A Multicenter, Double-blind, Randomized, Placebo-controlled Study of Weight-Reduction and/or Low Sodium Diet Plus Acetazolamide vs Diet Plus Placebo in Subjects With Idiopathic Intracranial Hypertension With Mild Visual Loss Completed NCT01003639 Phase 2, Phase 3 Acetazolamide;Placebo
29 A Randomized Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for Amblyopia in Children 7 to <13 Years Old Terminated NCT00587171 Phase 3
30 A Randomized Trial to Evaluate Combined Patching-Atropine for Residual Amblyopia Terminated NCT00506675 Phase 3 Atropine;Atropine
31 A Novel Therapeutic Strategy Targeting Photoreceptor Oxidative Damage in ABCR-related Retinal Degenerations Unknown status NCT01278277 Phase 1, Phase 2
32 Is Non-cycloplegic Photorefraction Applicable for Screening Refractive Risk Factors of Amblyopia? Completed NCT01308307 Phase 2
33 A Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia in 8 to 17 Year Olds Completed NCT00789672 Phase 2 levodopa/carbidopa;levodopa/carbidopa
34 Effectiveness of Telescopic Magnification in the Treatment of Amblyopia Completed NCT00970554 Phase 1, Phase 2
35 Evaluation and Development of a Novel Binocular Treatment (I-BiTTM) System Using Video Clips and Interactive Games to Improve Vision in Children With Amblyopia ('Lazy Eye'). Completed NCT01702727 Phase 2
36 Comparison of Photorefraction With Cycloautorefraction and Cycloretinoscopy at Emam Hosein Medical Centre in 2008-2009 Completed NCT00815581 Phase 1, Phase 2
37 Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants Completed NCT00349726 Phase 2 Inositol lower volume;Inositol higher volume;Placebo lower volume;Placebo higher volume
38 Phase II Randomized, Double-Masked, Placebo-Controlled, Safety, Pharmacokinetic, and Dose-Ranging Study of Multiple Doses of Inositol in Premature Infants Completed NCT01030575 Phase 2 Inositol lower volume;Inositol mid-level volume;Inositol high volume;Placebo low volume
39 THOR - Tübingen Choroideremia Gene Therapy Trial Open Label Phase 2 Clinical Trial Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein 1 (REP1) Active, not recruiting NCT02671539 Phase 2
40 Pilot Study to Evaluate Docosahexaenoic Acid as Treatment for Residual Amblyopia Not yet recruiting NCT03402789 Phase 1, Phase 2 Docosahexaenoic Acid;Placebo Oral Tablet
41 Caffeine in Amblyopia Study Withdrawn NCT02594358 Phase 1, Phase 2 Caffeine
42 Randomised Occlusion Treatment of Amblyopia Study (ROTAS): Trial of Maximal Vs Substantial Doses of Occlusion to Evaluate Visual Outcome for Children With Amblyopia Completed NCT00274664 Phase 1
43 Investigation of Visual Plasticity by a Direct Current Stimulation of Occipital Cortex in Adult Amblyopia Completed NCT00097162 Phase 1
44 A Singapore Pilot Study To Evaluate The Efficacy Of A Computerized System For The Vision Improvement Of People With Low Myopia Completed NCT00348127 Phase 1
45 Monovision for Treatment of Diplopia Completed NCT01426672 Phase 1
46 Pilot Study To Evaluate The Efficacy Of Neurovision'S NVC™- Vision Correction Technology For The Improvement In Visual Acuity In Myopic Children And Slowing Down Of Myopia Progression Completed NCT00348218 Phase 1
47 Recovery From Amblyopia With Cholinesterase Inhibitors Recruiting NCT01584076 Phase 1 Donepezil
48 Dichoptic Virtual Reality Therapy for Amblyopia in Adults Terminated NCT02246556 Phase 1
49 Phase 1 Study of Topical Beta Blocker to Prevent the Proliferative Stage of Infantile Hemangioma Terminated NCT01434849 Phase 1 topical 0.5% Timolol maleate;Control (placebo) group
50 Early Vision Screening With Automated Photorefraction in Pre-term, Low-birth- Weight and Development-delay Children in Far-Eastern Memorial Hospital, Taiwan Unknown status NCT02678468
51 Determining the Efficacy of Full-time Occlusion Therapy in Severe Amblyopia at All Ages Unknown status NCT02113709
52 The Role of Interactive Binocular Treatment System in Amblyopia Therapy Unknown status NCT02740725
53 The Use of Interactive Binocular Treatment (I-BiT) for the Management of Anisometropic, Strabismic and Mixed Amblyopia in Children Aged 3.5 - 12 Years Unknown status NCT02810847
54 New Pediatric Patching Method to Improve Compliance Unknown status NCT02236351
55 An Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to <7 Years Old Completed NCT00669539
56 Refractive and Strabismic Amblyopia Risk Factors Detected by Infrared Photoscreener and School Bus Skiascopy Completed NCT03668067
57 Comparative Validation of the Birefringent Amblyopia Screener With Isolated Small-angle Strabismus Completed NCT04195711
58 Standard Amblyopia Therapy in Adult Amblyopes Completed NCT03341780
59 Prospective Evaluation of a Smartphone Application, GoCheckKids™, to Detect Amblyopia Risk Factors in Young Children Completed NCT03447171
60 Pediatric Vision Scanner for the Eradication of Amblyopia Completed NCT01726842
61 Validation of a Questionnaire Assessing Quality of Life in Children With Amblyopia and Strabismus Completed NCT02880488
62 Assessment of Device for Treatment of Amblyopia Completed NCT02003235
63 Analysis of Spectral Domain Optical Coherence Tomography Measurements in Amblyopia Completed NCT01179763
64 Prospective Evaluation of a Smartphone Application, GoCheckKids™ as a Photo Screening Tool in a Pediatric Population Completed NCT03119675
65 Pediatric Vision Scanner 4 (PVS4) Completed NCT01832883
66 Luminopia VR Device Pilot Study Completed NCT02782117
67 MEPEDS New Device Pediatric Vision Scanner Completed NCT01706991
68 Does Video Game Play Induce Plasticity in the Visual System of Adults With Amblyopia? Completed NCT01223716
69 Vision Screening of the Four Year Old Children for the Detection of Amblyopia in The Town of Zagreb Completed NCT01430247
70 Multimodal Physician Intervention to Detect Amblyopia (Recruiting Title "Equipping Primary Care Physicians to Improve Care for Children") Completed NCT01109459
71 Study of Binocular Computer Activities for Treatment of Amblyopia Completed NCT02200211
72 Amblyopia and Strabismus Testing in Pediatrics Completed NCT02536963
73 Efficacy of Over-glasses Patch Treatment for Amblyopia in Children :OPTA Study, A Prospective Randomized Clinical Trial Completed NCT03080285
74 Analysis of Retinal Nerve Fiber Layer and Macular Thickness After Congenital Cataract Surgery Completed NCT03621579
75 Bilateral Refractive Amblyopia Treatment Study Completed NCT00305955
76 To Observe and Determine Macular Thickness Changes Before and After Cataract Surgery Completed NCT04077489
77 Glasses Versus Observation for Moderate Hyperopia in Young Children (HTS1) Completed NCT01515475
78 Disinvestment Study of Population-Based Vision Screening in Preverbal Children in the Netherlands Completed NCT01675193
79 Performance of Two Photoscreeners With Enhanced Housing Completed NCT04068129
80 AquaLase Capsule Wash for Pediatric Eyes Completed NCT00756327
81 Evaluation of a Visual Acuity Testing Software for Children, VisionQuest 20/20 Completed NCT00366756
82 Evaluation and Treatment Protocol for Patients With Pediatric Eye Diseases and Strabismus Completed NCT00006422
83 Binocular Treatment of Amblyopia Before and After Strabismus Surgery Completed NCT01791946
84 Visual Outcomes After Implantation of a Segmental Refractive Multifocal Intraocular Lens Following Cataract Surgery Completed NCT03452969
85 Test-Retest Variability of Quick Contrast Sensitivity Function Testing Completed NCT02177669
86 Visual Performance of New Apodized Diffractive Multifocal IOL With Addition of Plus Three Completed NCT01027533
87 A Long-term Postoperative Outcome After Bilateral Congenital Cataract Surgery in Eyes With Microphthalmos Completed NCT01818037
88 Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis Completed NCT02843438 Anti-toxoplasmosis treatment;Anti-inflammatory treatments
89 Effect of Neuromuscular Blockade on the Oculomotor by Not Squinting Child Completed NCT02360969
90 Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Nystagmus or Strabismus Completed NCT00001861
91 Antioxidant Systems and Age-Related Macular Degeneration Completed NCT00668213
92 Tertiary Care Based Visual Developmental Diseases Management Model Among Preschool Children in China: a Cluster Randomized Controlled Trial Completed NCT03251456
93 Assessing the Functional and Psychosocial Impact of Strabismus in Asian Children Using the AS-20 and IXTQ Questionnaires Completed NCT01608828
94 Effect of the Timing of Lens-removal Cataract Surgery on Postoperative Complications Rate Among Patients With Bilateral Congenital Cataracts Completed NCT02581046 Subconjunctival dexamethasone and general anesthesia
95 Wavefront Analysis and Contrast Sensitivity After Cataract Surgery With Akreos AO Intraocular Lens Implantation: Clinical Comparative Study Completed NCT00863759
96 A Novel Acuity Testing Method Completed NCT00013936
97 Effect of a Mobile Phone Short Message Service (SMS) on Childhood Cataract Follow-up Adherence in China Completed NCT01417819
98 Congenital Esotropia Observational Study (CEOS) Completed NCT00000163
99 Prescription of Hemangiol in the Treatment of Proliferative Infantile Hemangiomas Requiring Systemic Treatment: Post Marketing Surveillance Study Completed NCT04105517
100 Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular Degeneration Completed NCT04084587
101 Evaluation of Refractive Status and Ophthalmological Problems of Prematurity Completed NCT01045616
102 Augmented Medial Rectus Muscle Recession Versus Medial Rectus Recession With Posterior Scleral Fixation in Partially Accommodative Esotropia Completed NCT02413463
103 Evaluation of Choroidal Thickness Using Spectral Optical Coherence Tomography in Pseudoexfoliation Glaucoma and Primary Open Angle Glaucoma Completed NCT03373942
104 Evaluation of the Acrysof Toric SN60T3 Intraocular Lens in Patients With Predicted Residual Corneal Astigmatism Between 0.75 and 1.00 D. Completed NCT00542581
105 Examination of New Visual Acuity and Clinical Crowding Tests for Better Detection of Amblyopia Recruiting NCT03505606
106 Augmenting Patching Treatment for Amblyopia With Physical Exercise Recruiting NCT03822806
107 Binocular Dig Rush Game Treatment for Amblyopia Recruiting NCT02983552
108 Objective Adherence With Optical Correction in Children With Bilateral and Unilateral Refractive Amblyopia Recruiting NCT03780205
109 Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia Recruiting NCT02687581
110 Intense vs Standard Regimens of Intermittent Occlusion Therapy for Unilateral Moderate Amblyopia in Children Recruiting NCT02767856
111 Treating Amblyopia in Adults With Interactive Video Games Recruiting NCT03906994
112 Binocular Amblyopia Treatment Recruiting NCT03288948
113 Dichoptic Video Treatment for Amblyopia in Children Age 3-7 Years Recruiting NCT03825107
114 Improving Spatial and Temporal Vision in Adult and Juvenile Amblyopia Recruiting NCT01115283
115 Towards Developing a Perceptual Learning Treatment for Amblyopia Recruiting NCT03788031
116 Feasibility and Efficacy of Transcorneal Electrical Stimulation (TES) for the Treatment of Amblyopia Recruiting NCT02495935
117 Binocular iPad Sub-Study; Suppression in Amblyopia Recruiting NCT02365090
118 The Research of the Neural Mechanisms Underlying Astigmatism Recruiting NCT03735602
119 A Comparative Study Between Dissociative Treatment and Binocular Interactive Treatment in Amblyopia Recruiting NCT03255707
120 Photorefractive Keratectomy for Anisometropic and Isoametropic Amblyopia in Children Refractory to Conventional Treatment Recruiting NCT03610997
121 Neurovascular Coupling in Subjects With Amblyopia Recruiting NCT01746693
122 Binocular Visual Therapy and Video Games for Amblyopia Treatment. Recruiting NCT03655912
123 A Randomised Clinical Trial Objectively Comparing the Effect of Patching Therapy With Video Gaming for Amblyopia Recruiting NCT03767985
124 MRI-based Biomarkers for the Prognosis Judgement of Punctate White Matter Lesions in Neonates: a Longitudinal Multicenter Study Recruiting NCT02637817
125 Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences Recruiting NCT03940222
126 The Efficacy of a Visual Screening Program to Reduce Later Amblyopia and Untreated Refractive Errors Recruiting NCT02458846
127 Mobile Medical Application for Cost-effective Strabismus Screening Recruiting NCT03450980
128 The Effects of Regular Eye-training With a Mobile Device on Adult Patients With AMD Recruiting NCT03461393
129 The Effect of Peripheral Defocus on Axial Growth and Modulation of Refractive Error in Hyperopes Recruiting NCT02686879
130 Monofocal Extended Range of Vision (MERoV) Study Recruiting NCT04011696
131 Efficacy of Coloured Overlays and Lenses for Adults With Reading Difficulty Recruiting NCT02680223
132 Will Perceptual Learning Via Video Game Playing Improve Visual Acuity, Stereopsis and Fixation Stability in Mild Amblyopes? Part 2 Study Active, not recruiting NCT02995174
133 Optimized Visual Recovery in Adult Human Amblyopia Through Binocular Deprivation Active, not recruiting NCT02685423
134 The Long-Term Efficacy of Overminus Lens Therapy in Intermittent Exotropia Active, not recruiting NCT03952702
135 Use of Multifocal Contact Lenses to Stimulate Axial Elongation in Axial Hyperopia Active, not recruiting NCT00950924
136 A Randomized Trial of Bilateral Lateral Rectus Recession Versus Unilateral Lateral Rectus Recession With Medial Rectus Resection for Intermittent Exotropia Active, not recruiting NCT01032603
137 Visual Functional Connectivity and Visual Function in Amblyopia Before and After TMS and/or Binocular Treatment Enrolling by invitation NCT03151200
138 Improving Visual Functions in Young Children With Amblyopia Through Perceptual Learning Not yet recruiting NCT02555384
139 Efficacy and Safety of Eyetronix Flicker Glasses to the Treatment of Anisometropic Amblyopia in Chinese Children Not yet recruiting NCT02970708
140 The Effect of Light Deprivation on Visual Functions in Adult Amblyopes Not yet recruiting NCT02799836
141 Deploying Retinal Birefringence Imaging in to the Clinic for Pediatric Vision Screening Not yet recruiting NCT03919708
142 Excimer Laser Surgery for Anisometropic Amblyopia Not yet recruiting NCT03342235
143 Phase 2a Two-site Randomised Controlled Trial to Determine Safety of and Adherence With a New 'Binocularly Balanced Viewing' Treatment for Unilateral Amblyopia Compared With Standard Treatment in Children Age 3-8 Years Not yet recruiting NCT03754153
144 A Patch Free Treatment for Young Children With Amblyopia Not yet recruiting NCT04086524
145 Macular and Retinal Changes in Unilateral Amblyopia Using Optical Coherence Tomography Not yet recruiting NCT04092361
146 Müller's Muscle as a New Proprioceptive Organ Evidence From Immunohistochemical Staining and Electron Microscopy to Verify That the Upper Eyelid Müller's Muscle Contains Proprioceptive Innervation for Reflexive Correction of Eyelid Position Not yet recruiting NCT03396627
147 Improving Control of Alignment in Intermittent Esotropia Not yet recruiting NCT04199871
148 Medication Compliance in the Paediatric Uveitis Population Reported by the Patients and Parents Not yet recruiting NCT04148365
149 Botulinum Toxin Augmented Surgery Versus Conventional Surgery in the Management of Large Angle Infantile Esotropia Not yet recruiting NCT03266549
150 Use of a Novel, Objective Optokinetic Contrast Device to Determine Scotopic Range Visual Function and Discriminate Between Patients With and Without Glaucoma Suspended NCT02014597
151 Comparison of AmblyzTM Glasses and Patching for Amblyopia Terminated NCT01973348
152 Randomized Clinical Trial of OCT-guided Laser-assisted Lamellar Anterior Keratoplasty in Children Terminated NCT01579643
153 Amblyopia and Neurovascular Coupling in the Retina of Humans Withdrawn NCT00312390
154 Évaluation de l'Utilisation d'un Photoscreener Comme méthode de dépistage Des problèmes Ophtalmologiques pédiatriques en Haïti Withdrawn NCT02655432

Search NIH Clinical Center for Suppression Amblyopia

Cochrane evidence based reviews: amblyopia

Genetic Tests for Suppression Amblyopia

Anatomical Context for Suppression Amblyopia

MalaCards organs/tissues related to Suppression Amblyopia:

40
Eye, Testes, Cortex, Brain, Retina, Endothelial, Pituitary

Publications for Suppression Amblyopia

Articles related to Suppression Amblyopia:

(showing 7008, show less)
# Title Authors PMID Year
1
Amblyopia: Detection and Treatment. 61
31845774 2019
2
Altered functional interactions between neurons in primary visual cortex of macaque monkeys with experimental amblyopia. 61
31553685 2019
3
Outcomes of surgery in patients with sensory exotropia. 61
31836297 2019
4
The practise of paediatric optometry in a low-resource environment. 61
31852024 2019
5
Evidence-based clinical practice guidelines for the periodic eye examination in children aged 0-5 years in Canada. 61
31767160 2019
6
Efficacy of toric intraocular lens implantation with high corneal astigmatism within the United Kingdom's National Health Service. 61
31844167 2019
7
[Treatment monitoring and innovations in amblyopia treatment]. 61
31552468 2019
8
Analysis of Macular Vessel Density and Foveal Avascular Zone in Adults with Amblyopia. 61
31283893 2019
9
Comparison between patching and interactive binocular treatment in amblyopia: A randomized clinical trial. 61
31844795 2019
10
Current Management of Childhood Amblyopia. 61
31833253 2019
11
Brain abnormalities in infantile esotropia as predictor for consecutive exotropia. 61
31637944 2019
12
Strabismus Patterns in Patients with Intrauterine Drug Exposure. 61
31852370 2019
13
The Danish Rural Eye Study: prevalence of strabismus among 3785 Danish adults - a population-based cross-sectional study. 61
31025814 2019
14
[Do children with strabismus receive ophthalmic treatment? : Results from the KiGGS (German Health Interview and Examination Survey for Children and Adolescents) baseline survey (2003-2006)]. 61
30980175 2019
15
Posterior microphthalmos with good visual acuity: A case report. 61
31763497 2019
16
Optical Coherence Tomography Normative Peripapillary Retinal Nerve Fiber Layer and Macular Data in Children 0-5 Years of Age. 61
31271744 2019
17
Children with congenital and childhood cataract require frequent follow-up visits and examinations in general anaesthesia: considerations for the strain on families. 61
30860655 2019
18
The impact of vision screening in preschool children on visual function in the Swedish adult population. 61
31127702 2019
19
[Vision screening in children: Review of the literature]. 61
31733915 2019
20
Intact Visuospatial Cognition in Amblyopia: Results From the Gutenberg Health Study. 61
31743409 2019
21
Assessment of stereovision with digital testing in adults and children with normal and impaired binocularity. 61
31377344 2019
22
[Orbital Disorders in Childhood]. 61
31412385 2019
23
Objective and quantitative assessment of interocular suppression in strabismic amblyopia based on steady-state motion visual evoked potentials. 61
31585388 2019
24
Referral to community care from school-based eye care programs in the United States. 61
30978336 2019
25
Ophthalmological management in craniosynostosis. 61
31574284 2019
26
[Ametropia among senegalese children in a hospital setting]. 61
31235321 2019
27
Optical Coherence Tomography Angiography in Amblyopia. 61
31755981 2019
28
Surgical Intervention of Periocular Infantile Hemangiomas in the Era of β-Blockers. 61
31809485 2019
29
Epibulbar complex choristoma with simultaneous involvement of eyelid: a case report. 61
31718612 2019
30
Horizontal Gaze Palsy with Progressive Scoliosis: A Case Report and Literature Review. 61
31741681 2019
31
Aniseikonia and anisometropia: implications for suppression and amblyopia. 61
30791133 2019
32
Altered cortical morphology of visual cortex in adults with monocular amblyopia. 61
30854758 2019
33
Global prevalence of amblyopia and disease burden projections through 2040: a systematic review and meta-analysis. 61
31704700 2019
34
Full time occlusion VS part time occlusion in treatment of monocular amblyopia. 61
31777509 2019
35
Systematic Evaluation of Levodopa Effect on Visual Improvement in Amblyopia: A Meta-analysis. 61
31738189 2019
36
Abnormal Monocular and Dichoptic Temporal Synchrony in Adults with Amblyopia. 61
31747686 2019
37
Effect of Primary Occlusion Therapy in Asymmetric, Bilateral Amblyopia. 61
31712066 2019
38
Incidence of strabismus and amblyopia among children initially diagnosed with pseudostrabismus using the Optum® dataset. 61
31730842 2019
39
Performance of the 2WIN Photoscreener With "CR" Strabismus Estimation in High-Risk Patients. 61
31077668 2019
40
Long-term monocular deprivation during juvenile critical period disrupts binocular integration in mouse visual thalamus. 61
31767678 2019
41
[Keratoplasty in children : Indications and results]. 61
31713069 2019
42
Periocular infantile hemangiomas: Characteristics, ocular sequelae, and outcomes. 61
31448460 2019
43
Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity. 61
31697304 2019
44
Biallelic ERBB3 loss-of-function variants are associated with a novel multisystem syndrome without congenital contracture. 61
31752936 2019
45
Spontaneous regression of congenital corneal opacity. 61
31768679 2019
46
Abnormal sensory eye dominance in stereoanomalous subjects. 61
31747692 2019
47
Anterior lamellar keratoplasty for the management of a central dermoid tumour in a baby. 61
31735598 2019
48
Management of a Large Congenital Hemangioma Obstructing Visual Axis: A Case Report and Review of Literature. 61
31593044 2019
49
Vision Testing Among Children Aged 3-5 Years in the United States, 2016-2017. 61
31751209 2019
50
Use of a new composite index to demonstrate improved stereoacuity after training on stimuli with dichoptically asymmetric contrast. 61
31735256 2019
51
Retinal oximetry in normal and amblyopic children: a pilot study. 61
30843376 2019
52
Altered spontaneous brain activity in patients with strabismic amblyopia: A resting-state fMRI study using regional homogeneity analysis. 61
31616514 2019
53
Ophthalmologic disorders and risk factors in children with autism spectrum disorder. 61
31676470 2019
54
[Evaluation of Ophthalmic Follow-up Care of Former Pre-term and Full-term Infants Aged from 4 to 10 Years in Germany - Results of the Wiesbaden Prematurity Study (WPS)]. 61
29117610 2019
55
Anterior chamber depth and axial length affect clinical performance of Spot Vision Screener. 61
31664336 2019
56
Congenital glycosylation disorder: a novel presentation of coexisting anterior and posterior segment pathology and its implications in pediatric cataract management. 61
31153949 2019
57
Objective measurement of visual acuity by optokinetic nystagmus suppression in children and adult patients. 61
31526857 2019
58
Comparison of 2Win and plusoptiX A12R refractometers with Retinomax handheld autorefractor keratometer. 61
31539614 2019
59
Refractive Errors and Amblyopia Among Children Screened by the UCLA Preschool Vision Program in Los Angeles County. 61
31647932 2019
60
Attention deficits in Amblyopia. 61
31030000 2019
61
The Role of Binocularity in Anisometropic Amblyopia. 61
31486743 2019
62
An Unexpected Spontaneous Motion-In-Depth Pulfrich Phenomenon in Amblyopia. 61
31735855 2019
63
Effects of temporal frequency on binocular deficits in amblyopia. 61
31404553 2019
64
Amblyopia with Eccentric Fixation: Is Inverse Occlusion Still an Option? 61
31584348 2019
65
[The Use of a Microsensor in Therapy of Amblyopia]. 61
29117611 2019
66
Binocular Treatment of Amblyopia: A Report by the American Academy of Ophthalmology. 61
31619356 2019
67
[Syndrome of bilateral myelinated retinal nerve fibers, myopia and amblyopia: A case report]. 61
31182255 2019
68
Analysis of retinal nerve fiber layer thickness in anisometropic amblyopia via optic coherence tomography. 61
31270595 2019
69
Differential Experience-Dependent Plasticity of Form and Motion Mechanisms in Anisometropic Amblyopia. 61
31574139 2019
70
Expanding the phenotypic spectrum of MBOAT7-related intellectual disability. 61
31282596 2019
71
Accuracy of online health information on amblyopia and strabismus. 61
31610240 2019
72
Autonomous early detection of eye disease in childhood photographs. 61
31616792 2019
73
Long-term visual outcomes following abusive head trauma with retinal hemorrhage. 61
31655114 2019
74
Evaluation of Metabolite Changes in the Occipital Cortex of Patients with Idiopathic Infantile Nystagmus or Bilateral Ametropic Amblyopia by Magnetic Resonance Spectroscopy. 61
31612650 2019
75
Quality of life and mental health in amblyopic children treated with and without occlusion therapy. 61
31678257 2019
76
Evidence-based preschool-age vision screening: health policy considerations. 61
31514739 2019
77
Ocular characteristics in a variant microcephalic primordial dwarfism type II. 61
31510961 2019
78
Choosing appropriate tools and referral criteria for vision screening of children aged 4-5 years in Canada: a quantitative analysis. 61
31558460 2019
79
How Many Plusoptix S04 Measures Yield the Most Sensitive Amblyopia Screening? 61
31545864 2019
80
Simplified updates on the pathophysiology and recent developments in the treatment of amblyopia: A review. 61
31436180 2019
81
The Importance of the Interaction Between Ocular Motor Function and Vision During Human Infancy. 61
31525140 2019
82
[Ocular torticollis is a diagnostic and surgical challenge]. 61
31543099 2019
83
Does successful surgical correction of childhood large angle exotropia in adults make any difference to binocularity and quality of life? 61
31335253 2019
84
Eye Conditions in Infants and Children: Vision Screening and Routine Eye Examinations. 61
31454212 2019
85
Biometry: a tool for the detection of amblyopia risk factor in children. 61
31183540 2019
86
Anisometropia and isoametropia associated with microstrabismus: effectiveness of late anti-amblyopia treatment. 61
31612190 2019
87
Optical treatment of strabismic amblyopia. 61
31506980 2019
88
Treatment of amblyopia: part 5. 61
31456466 2019
89
Surgical intervention for paediatric blepharoptosis: a 6-year case series. 61
30244388 2019
90
Evaluation of static and dynamic pupil characteristics in hyperopic anisometropic amblyopia. 61
30284453 2019
91
Amblyopia treatment and quality of life: the child's perspective on atropine versus patching. 61
31329017 2019
92
Eye Conditions in Infants and Children: Amblyopia and Strabismus. 61
31454213 2019
93
Eye Tracking Abnormalities in School-Aged Children With Strabismus and With and Without Amblyopia. 61
31545863 2019
94
Two-Year Outcomes of Infants with Stage 2 or Higher Retinopathy of Prematurity: Results from a Large Multicenter Registry. 61
31480086 2019
95
[Congenital abnormalities of the optic disc]. 61
30935696 2019
96
Clinical characteristics and mutation Spectrum of NF1 in 12 Chinese families with orbital/periorbital plexiform Neurofibromatosis type 1. 61
31533651 2019
97
Bilateral Congenital Corneal Opacities as an Early-Onset Ocular Feature of Kabuki Syndrome. 61
30950893 2019
98
Sex-specific difference in age distribution of congenital lower eyelid epiblepharon in a Japanese population. 61
31286315 2019
99
A comparison of ocular trauma scores in a pediatric population. 61
31511037 2019
100
[Recurrent maxillary sinus pleomorphic gonadoma into myoepithelial carcinoma: a case report]. 61
31446713 2019
101
Smartphone use in ophthalmology: What is their place in clinical practice? 61
31541618 2019
102
tDCS recovers depth perception in adult amblyopic rats and reorganizes visual cortex activity. 61
31078617 2019
103
Comparison of the CAT-QoL and PedsQLTM instruments in measuring quality of life in amblyopia treatment: preliminary results. 61
31120350 2019
104
Referral for Ophthalmology Evaluation and Visual Sequelae in Children With Primary Brain Tumors. 61
31373649 2019
105
Impaired Fellow Eye Motion Perception and Abnormal Binocular Function. 61
31387113 2019
106
Foveal avascular zone and macular vessel density after correction for magnification error in unilateral amblyopia using optical coherence tomography angiography. 61
31382925 2019
107
[An investigation on professional performance of optometric refraction in spectacles stores in Anyang city of Henan Province]. 61
31422635 2019
108
Prevalence of anterior polar cataracts in children and risk factors for amblyopia. 61
30390373 2019
109
Transcranial Magnetic Stimulation in Adults With Amblyopia. 61
31453915 2019
110
Conventional occlusion versus pharmacologic penalization for amblyopia. 61
31461545 2019
111
Feasibility of monitoring compliance with intermittent occlusion therapy glasses for amblyopia treatment. 61
31271842 2019
112
Driver licensing and motor vehicle crash rates among young adults with amblyopia and unilateral vision impairment. 61
30769086 2019
113
Morphologic changes in the visual cortex of patients with anisometropic amblyopia: a surface-based morphometry study. 61
31375091 2019
114
Analysis of Choroidal Vascularity in Children with Unilateral Hyperopic Amblyopia. 61
31434959 2019
115
The effect of asymmetrical accommodation on anisometropic amblyopia treatment outcomes. 61
31301347 2019
116
Amblyopia Affects the ON Visual Pathway More than the OFF. 61
31189574 2019
117
Marcus Gunn Jaw-Winking Syndrome: a Case Report. 61
31762566 2019
118
Ocular dominance plasticity: A binocular combination task finds no cumulative effect with repeated patching. 61
31194984 2019
119
Novel BRPF1 mutation in a boy with intellectual disability, coloboma, facial nerve palsy and hypoplasia of the corpus callosum. 61
31176769 2019
120
Zone of retinal vascularization and refractive error in premature eyes with and without spontaneously regressed retinopathy of prematurity. 61
31229607 2019
121
Cost-Effectiveness of Limited Vitrectomy for Vision-Degrading Myodesopsia. 61
30849342 2019
122
Eyelid Thread-lifting Treatment for Periocular Infantile Hemangioma in an Extremely Premature Low-birth-weight Infant. 61
31592024 2019
123
Colour vision testing in young children with reduced visual acuity. 61
31469512 2019
124
Study on the High Functional Contact Lens Material with Superior Oxygen Transmissibility and Antibacterial Properties. 61
30913731 2019
125
Factors determining the outcome of paediatric exotropia surgery. 61
31424031 2019
126
Quantitative analysis of retinal microcirculation in children with hyperopic anisometropic amblyopia: an optical coherence tomography angiography study. 61
31112776 2019
127
Comparison of amblyopia in schoolchildren in Ireland and Northern Ireland: a population-based observational cross-sectional analysis of a treatable childhood visual deficit. 61
31401612 2019
128
Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens. 61
31429729 2019
129
Clinical investigation plan for the use of interactive binocular treatment (I-BiT) for the management of anisometropic, strabismic and mixed amblyopia in children aged 3.5-12 years: a randomised controlled trial. 61
31311577 2019
130
Duane's Retraction Syndrome in a Cohort of South African Children: A 20-Year Clinic-Based Review. 61
31322716 2019
131
Diagnostic test accuracy of Spot and Plusoptix photoscreeners in detecting amblyogenic risk factors in children: a systemic review and meta-analysis. 61
31236980 2019
132
School screening in Coastal Karnataka. 61
31687626 2019
133
The Outcome of Scleral Lens Fitting for Keratoconus With Resolved Corneal Hydrops. 61
31170103 2019
134
Regression of fetal vasculature and visual improvement in nonsurgical persistent hyperplastic primary vitreous: a case report. 61
31349817 2019
135
Fellow Eye Deficits in Amblyopia. 61
31161888 2019
136
Video interpretation and diagnosis of pediatric amblyopia and eye disease. 61
31364472 2019
137
Dichoptic De-Masking Learning in Adults With Amblyopia and Its Mechanisms. 61
31307059 2019
138
A Convenient and Robust Test to Quantify Interocular Suppression for Children With Amblyopia. 61
31384415 2019
139
OCT angiography of persistent hyaloid artery: a case report. 61
31272412 2019
140
A commonly occurring genetic variant within the NPLOC4-TSPAN10-PDE6G gene cluster is associated with the risk of strabismus. 61
31073882 2019
141
Comparative study of visual dysfunctions in 6-10-year-old very preterm- and full-term-born children. 61
29916121 2019
142
Tribal Odisha Eye Disease Study (TOES) report # 5: Comparison of prevalence and causes of visual impairment among tribal children in native and urban schools of Odisha (India). 61
31238398 2019
143
Visual outcome and surgical results in children with Marfan syndrome. 61
31325202 2019
144
Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus? 61
31296236 2019
145
A Review of Childhood Vision Screening Laws and Programs Across the United States. 61
31461584 2019
146
Visual Acuity and Ophthalmic Outcomes in the Year After Cataract Surgery Among Children Younger Than 13 Years. 61
31095258 2019
147
Oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial. 61
30783259 2019
148
Analysis of macular, foveal, and retinal nerve fiber layer thickness in children with unilateral anisometropic amblyopia and their changes following occlusion therapy. 61
31238399 2019
149
Commentary: Analysis of macular, foveal and retinal nerve fiber layer thickness in children with unilateral anisometropic amblyopia and their changes following occlusion therapy. 61
31238400 2019
150
Don't Miss This! Red Flags in the Pediatric Eye Examination: Subnormal Acuity. 61
31329058 2019
151
Binocular game versus part-time patching for treatment of anisometropic amblyopia in Chinese children: a randomised clinical trial. 61
31272953 2019
152
Comparison of higher order aberrations in amblyopic and non-amblyopic eyes in pediatric patients with anisometropic amblyopia. 61
31238401 2019
153
Status of visual impairment among indigenous (Orang Asli) school children in Malaysia. 61
31196018 2019
154
Factors influencing stereopsis in patients with both refractive accommodative esotropia and amblyopia. 61
29704131 2019
155
Fixation instability during binocular viewing in anisometropic and strabismic children. 61
30006273 2019
156
Plusoptix photoscreener use for paediatric vision screening in Flanders and Iran. 61
31197950 2019
157
Patterns of uveitis in children according to age: comparison of visual outcomes and complications in a tertiary center. 61
31248388 2019
158
The absence of fundus abnormalities in Stargardt disease. 61
30903310 2019
159
The history of the Ostschweizerische Pleoptik und Orthoptik Schule in St. Gallen. 61
31151365 2019
160
Treatment of amblyopia: part 4. 61
31134846 2019
161
Updates on managements of pediatric cataract. 61
31317088 2019
162
Binocular amblyopia treatment with contrast-rebalanced movies. 61
31103562 2019
163
Refinement of the Child Amblyopia Treatment Questionnaire (CAT-QoL) using Rasch analysis. 61
31012391 2019
164
Suprathreshold Motion Perception in Anisometropic Amblyopia: Interocular Speed Matching and the Pulfrich Effect. 61
31107841 2019
165
Long-term Effects After Pediatric LASIK for Anisometropic Amblyopia in Two Patients. 61
31185105 2019
166
Amblyopia therapy in Asian children: factors affecting visual outcome and parents' perception of children's attitudes towards amblyopia treatment. 61
30488078 2019
167
The treatment of amblyopia: current practice and emerging trends. 61
30706134 2019
168
Audiovisual perception in amblyopia: A review and synthesis. 61
29758189 2019
169
False corneal ectasia in patients referred for corneal crosslinking, topography-guided photorefractive keratectomy, and intrastromal corneal rings. 61
31109479 2019
170
A clinicopathological study of persistent fetal vasculature. 61
31124487 2019
171
Refractive, sensory, and biometric outcome among retinopathy of prematurity children with a history of laser therapy: A retrospective review from a tertiary care center in South India. 61
31124505 2019
172
Altered brain activity in patients with strabismus and amblyopia detected by analysis of regional homogeneity: A resting‑state functional magnetic resonance imaging study. 61
31059016 2019
173
Outcomes following surgery for horizontal strabismus in children of lower socioeconomic backgrounds. 61
31184517 2019
174
Vision and visual potential for perifoveal retinoblastoma after optical coherence tomographic-guided sequential laser photocoagulation. 61
29976784 2019
175
Characteristic patterns of segmental infantile hemangiomas in Indian children: A descriptive study. 61
31169257 2019
176
The effect of different amblyopia treatment protocols on axial length of non-amblyopic eyes in anisohyperopic patients. 61
31317100 2019
177
Microvascular changes in amblyopic eyes detected by optical coherence tomography angiography. 61
31004783 2019
178
Corneal indices following photorefractive keratectomy in children at least 5 years after surgery. 61
31103563 2019
179
Self-perception in Children Aged 3 to 7 Years With Amblyopia and Its Association With Deficits in Vision and Fine Motor Skills. 61
30763432 2019
180
Amblyopia Elimination Project: Pediatric Medical Home-Based Community Vision Screening. 61
31116860 2019
181
Variants in myelin regulatory factor (MYRF) cause autosomal dominant and syndromic nanophthalmos in humans and retinal degeneration in mice. 61
31048900 2019
182
[Features of clinical application of eye acupuncture therapy revealed by data mining]. 61
31155873 2019
183
Clarifications to Consider Regarding Multiple-Choice Answer Form Completion Time in Children With Amblyopia and Strabismus. 61
30844020 2019
184
Functional limitations recognised by adults with amblyopia and strabismus in daily life: a qualitative exploration. 61
30957266 2019
185
Clarifications to Consider Regarding Multiple-Choice Answer Form Completion Time in Children With Amblyopia and Strabismus-Reply. 61
30844066 2019
186
Visual improvement in amblyopic eye following treatment-induced vision loss in dominant eye with uveal melanoma. 61
31097438 2019
187
PARS PLANA VITRECTOMY WITH ANTERIOR CHAMBER VERSUS GORE-TEX SUTURED POSTERIOR CHAMBER INTRAOCULAR LENS PLACEMENT: Long-Term Outcomes. 61
29346243 2019
188
Intraocular lens implantation in children with unilateral congenital cataract in the first 4 years of life. 61
30060694 2019
189
The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity. 61
31078540 2019
190
[Amblyopia-Basic principles and current diagnostic and therapeutic standards]. 61
30888470 2019
191
Clinical Profile and Treatment Outcomes of Amblyopia Across Age Groups. 61
31543663 2019
192
Types of materials for frontalis sling surgery for congenital ptosis. 61
31013353 2019
193
[Ocular Phenotype and Complications in Patients with Tuberous Sclerosis Complex (TSC)]. 61
30763959 2019
194
Clinical Profile of Low Vision Patients Attending in Low Vision Clinic in a Tertiary Care Hospital. 61
31086157 2019
195
Compared performance of Spot and SW800 photoscreeners on Chinese children. 61
29986946 2019
196
Pediatric keratoconus misdiagnosed as meridional amblyopia. 61
30900595 2019
197
Two cortical deficits underlie amblyopia: A multifocal fMRI analysis. 61
28943411 2019
198
Gap effect and express saccades generation in amblyopia. 61
30977772 2019
199
Treatment outcomes for amblyopia using PEDIG amblyopia protocols: a retrospective study of 877 cases. 61
30935990 2019
200
Binocular treatment in adult amblyopia is based on parvocellular or magnocellular pathway. 61
31014078 2019
201
Comparing Three Different Contrast Sensitivity Tests in Adults and in Children with and without Amblyopia. 61
30999326 2019
202
Assessment of macular vascular plexus density using optical coherence tomography angiography in cases of strabismic amblyopia. 61
30900586 2019
203
Visual outcomes and complications of congenital cataract surgery. 61
30898370 2019
204
Pediatric Periocular Dermoid Cysts: Incidence, Clinical Characteristics, and Surgical Outcomes. 61
30260262 2019
205
Detecting Anti-IIa and Anti-Xa Direct Oral Anticoagulant (DOAC) Agents in Urine using a DOAC Dipstick. 61
30134449 2019
206
Mirror image hypermetropic anisometropia in a pair of monozygotic twins. 61
30458238 2019
207
Early isolated optic neuropathy caused by cyclosporine. 61
29532216 2019
208
Vision Screening in Children in the Canton of St. Gallen. 61
30646426 2019
209
"PI-less DMEK": results of Descemet's membrane endothelial keratoplasty (DMEK) without a peripheral iridotomy. 61
30518974 2019
210
Factors influencing myopic shift in children after intraocular lens implantation. 61
31025587 2019
211
Binocular non-stereoscopic cues can deceive clinical tests of stereopsis. 61
30962466 2019
212
Binocular vision and fixational eye movements. 61
30943531 2019
213
White matter microstructural alterations in amblyopic adults revealed by diffusion spectrum imaging with systematic tract-based automatic analysis. 61
29844086 2019
214
Patient-oriented mobile applications in ophthalmology. 61
30168194 2019
215
A Randomized Trial of Binocular Dig Rush Game Treatment for Amblyopia in Children Aged 7 to 12 Years. 61
30352226 2019
216
Reading ability of children treated for amblyopia. 61
30633876 2019
217
Evaluation of vision screening in five- to eight-year-old children living in Region Västra Götaland, Sweden - a prospective multicentre study. 61
30280519 2019
218
Evaluation of nutritional status in children with amblyopia. 61
30726406 2019
219
Adherence syndrome following inferior oblique anteropositioning - a case report. 61
30570375 2019
220
Contrast and spatial frequency modulation for diagnosis of amblyopia: An electrophysiological approach. 61
30899850 2019
221
Impaired Spatial Hearing in Amblyopia: Evidence for Calibration of Auditory Maps by Retinocollicular Input in Humans. 61
30849170 2019
222
Use of log-scaled crowded visual acuity charts in clinical studies regarding amblyopia. 61
30675642 2019
223
Late Ophthalmologic Referral of Anisometropic Amblyopia: A Retrospective Study of Different Amblyopia Subtypes. 61
30946787 2019
224
Case Series: Pediatric Herpes Simplex Keratitis. 61
30801497 2019
225
Incidence and risk of attention-deficit hyperactivity disorder in children with amblyopia: A nationwide cohort study. 61
30663207 2019
226
Amblyopia Risk Factors in Premature Children in the First 3 Years of Life. 61
30889262 2019
227
Correction to: development of a core outcome set for amblyopia, strabismus and ocular motility disorders: a review to identify outcome measures. 61
30857536 2019
228
Acquired Pediatric Brown Syndrome Secondary to Sinusitis. 61
30907972 2019
229
Portable System for Neuro-Optical Diagnostics Using Virtual Reality Display. 61
30901414 2019
230
Different trajectories in the development of visual acuity with different levels of crowding: The Milan Eye Chart (MEC). 61
30639454 2019
231
Retinal Microvasculature in Amblyopic Children and the Quantitative Relationship Between Retinal Perfusion and Thickness. 61
30913291 2019
232
Objective vision screening using PlusoptiX for children aged 3-11 years in rural Turkey. 61
30871506 2019
233
Validation of dynamic random dot stereotests in pediatric vision screening. 61
30284041 2019
234
Visual acuity and amblyopia prevalence in 11- to 12-year-old Danish children from the Copenhagen Child Cohort 2000. 61
30280496 2019
235
Visual function in children with primary brain tumors. 61
30516642 2019
236
Self-perception of School-aged Children With Amblyopia and Its Association With Reading Speed and Motor Skills. 61
30452518 2019
237
Causes of visual impairment in applications for blindness certificates in a tertiary center of Bihar and its role in health planning. 61
30672470 2019
238
Visual prognosis of posterior and combined persistent fetal vasculature. 61
30712383 2019
239
A new counterintuitive training for adult amblyopia. 61
30847360 2019
240
Evaluation of choroidal thickness in amblyopia using optical coherence tomography. 61
30808182 2019
241
Childhood Self-perceptions in Children With Amblyopia: Is the Problem the Disease or the Treatment? 61
30452493 2019
242
Development of a core outcome set for amblyopia, strabismus and ocular motility disorders: a review to identify outcome measures. 61
30736755 2019
243
Prevalence of amblyopia and strabismus in Hani school children in rural southwest China: a cross-sectional study. 61
30782934 2019
244
[CHILDHOOD GLAUCOMA]. 61
30779490 2019
245
Neuregulin directed molecular mechanisms of visual cortical plasticity. 61
29464684 2019
246
Intranasal BDNF administration promotes visual function recovery in adult amblyopic rats. 61
29428822 2019
247
Refractive adaptation and efficacy of occlusion therapy in untreated amblyopic patients aged 12 to 40 years. 61
30397791 2019
248
Physical, chemical, and microbiological stability study of diluted atropine eye drops. 61
31844539 2019
249
From suppression to stereoacuity: a composite binocular function score for clinical research. 61
30628744 2019
250
Analysis of Macular Vessel Density and Foveal Avascular Zone Using Spectral-Domain Optical Coherence Tomography Angiography in Children With Amblyopia. 61
30371915 2019
251
From Basic Visual Science to Neurodevelopmental Disorders: The Voyage of Environmental Enrichment-Like Stimulation. 61
31198418 2019
252
Imaging Amblyopia: Insights from Optical Coherence Tomography (OCT). 61
31158044 2019
253
Prevalence of amblyopia among preschool children in central south China. 61
31131243 2019